TEVA PHARMACEUTICAL INDUSTRIES LIMITED Dividends Paid
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Dividends Paid of $496.00 million for the 9-month period ending 2010-09-30, per its 6-K filed 2010-11-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividends · last filed 2010-11-02
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of dividends for the quarter ending 2010-09-30 was $167.00M, a 32.54% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of dividends for the quarter ending 2010-06-30 was $164.00M, a 22.39% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of dividends for the quarter ending 2010-03-31 was $165.00M, a 29.92% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of dividends for the quarter ending 2009-12-31 was $141.00M, a 56.67% increase year-over-year.
| Period end | Payments of Dividends 3 month | Payments of Dividends 6 month | Payments of Dividends 9 month | Payments of Dividends 12 month |
|---|---|---|---|---|
| 2010-09-30 | $167.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | $331.00M derived: sum of 2 quarters · filed 2010-11-02 | $496.00M 6-K · filed 2010-11-02 | $637.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2010-06-30 | $164.00M derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | $329.00M 6-K · filed 2010-07-27 | $470.00M derived: sum of 3 quarters · filed 2010-07-27 | $596.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2010-03-31 | $165.00M 6-K · filed 2010-05-04 | $306.00M derived: sum of 2 quarters · filed 2010-05-04 | $432.00M derived: sum of 3 quarters · filed 2010-11-02 | $566.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2009-12-31 | $141.00M derived: 20-F 12 month − 6-K 9 month · filed 2010-02-22 | $267.00M derived: sum of 2 quarters · filed 2010-11-02 | $401.00M derived: sum of 3 quarters · filed 2010-11-02 | $528.00M 20-F · filed 2010-02-22 |
| 2009-09-30 | $126.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | $260.00M derived: sum of 2 quarters · filed 2010-11-02 | $387.00M 6-K · filed 2010-11-02 | $477.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2009-06-30 | $134.00M derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | $261.00M 6-K · filed 2010-07-27 | $351.00M derived: sum of 3 quarters · filed 2010-07-27 | $448.00M derived: sum of 4 quarters · filed 2010-07-27 |
| 2009-03-31 | $127.00M 6-K · filed 2010-05-04 | $217.00M derived: sum of 2 quarters · filed 2010-05-04 | $314.00M derived: sum of 3 quarters · filed 2010-05-04 | $420.00M derived: sum of 4 quarters · filed 2010-05-04 |
| 2008-12-31 | $90.00M derived: 20-F 12 month − 6-K 9 month · filed 2010-02-22 | $187.00M derived: sum of 2 quarters · filed 2010-02-22 | $293.00M derived: sum of 3 quarters · filed 2010-02-22 | $388.00M 20-F · filed 2010-02-22 |
| 2008-09-30 | $97.00M derived: 6-K 9 month − 6-K 6 month · filed 2009-11-03 | $203.00M derived: sum of 2 quarters · filed 2009-11-03 | $298.00M 6-K · filed 2009-11-03 | |
| 2008-06-30 | $106.00M derived: 6-K 6 month − 6-K 3 month · filed 2009-07-29 | $201.00M 6-K · filed 2009-07-29 | ||
| 2008-03-31 | $95.00M 6-K · filed 2009-05-07 | |||
| 2007-12-31 | $299.00M 20-F · filed 2010-02-22 |